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Abstract
Poxviruses encode a large variety of proteins that mimic, block or enhance host cell signaling pathways on their own
benefit. It has been reported that mitogen-activated protein kinases (MAPKs) are specifically upregulated during vaccinia
virus (VACV) infection. Here, we have evaluated the role of the MAPK negative regulator dual specificity phosphatase 1
(DUSP1) in the infection of VACV. We demonstrated that DUSP1 expression is enhanced upon infection with the replicative
WR virus and with the attenuated VACV viruses MVA and NYVAC. This upregulation is dependent on early viral gene
expression. In the absence of DUSP1 in cultured cells, there is an increased activation of its molecular targets JNK and ERK
and an enhanced WR replication. Moreover, DUSP1 knock-out (KO) mice are more susceptible to WR infection as a result of
enhanced virus replication in the lungs. Significantly, MVA, which is known to produce non-permissive infections in most
mammalian cell lines, is able to grow in DUSP1 KO immortalized murine embryo fibroblasts (MEFs). By confocal and electron
microscopy assays, we showed that in the absence of DUSP1 MVA morphogenesis is similar as in permissive cell lines and
demonstrated that DUSP1 is involved at the stage of transition between IVN and MV in VACV morphogenesis. In addition,
we have observed that the secretion of pro-inflammatory cytokines at early times post-infection in KO mice infected with
MVA and NYVAC is increased and that the adaptive immune response is enhanced in comparison with WT-infected mice.
Altogether, these findings reveal that DUSP1 is involved in the replication and host range of VACV and in the regulation of
host immune responses through the modulation of MAPKs. Thus, in this study we demonstrate that DUSP1 is actively
involved in the antiviral host defense mechanism against a poxvirus infection.
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Introduction
Poxviruses have evolved to efficiently counteract host immune
responses through the modulation of extracellular and intracellular
environment of the infected cell. Thereby, the ability of a poxvirus
to produce a permissive infection in a specific cell type depends on
the antiviral mechanisms that the virus is able to block once it
infects the cell. VACV is the prototype member of the Poxvirus
family, whose large genome of about 200 Kbp encodes a wide
array of proteins involved in the control of apoptosis, differenti-
ation, host range, host immune responses and stress-induced
signaling pathways [1], [2], [3], [4], [5], [6], [7].
Protein phosphorylation is a conserved mechanism by which the
activity of numerous proteins involved in different biological
processes is switched on or off [8]. Transient activation of
extracellular-regulated kinase (ERK) and jun-kinase (JNK)
MAPKs is an essential step in the pathways involved in cellular
survival. Therefore, several viruses have evolved to develop
strategies that consist of the modulation of these proteins [9],
[10], [11]. A specific modulation of cell signaling pathways by
VACV is crucial to achieve a productive viral outcome and an
efficient viral spread [12], [13]. Hence, VACV not only encodes its
own kinases and phosphatases [14], [15], [16] but it is also able to
benefit from the activity of cellular proteins such as the ones
belonging to the family of MAPKs which consists of p38MAPK,
ERK and JNK. For instance, it has been reported that VACV
requires ERK activation for an efficient viral replication [17].
MAPKs are involved in important cellular pathways by regulating
both physiological and pathological responses that include
proliferation, differentiation, stress responses, inflammation,
growth arrest and apoptosis [18], [19], [20]. Since MAPKs suffer
a context-dependent regulation, a tight control of the magnitude
and duration of MAPK activation as well as their subcellular
localization are essential for a balanced MAPK signaling [21].
Therefore, as MAPKs are activated by phosphorylation by
upstream MAPKKs [22], the cell encodes phosphatases that
specifically bind to MAPKs and inactivate them by removing the
phosphates on the Thr-Xaa-Tyr motif. Among these phosphatas-
es, DUSPs provide an important negative feedback mechanism for
MAPK activation [23]. The family of DUSPs shares a common
kinase interaction motif (KIM) located at the N-terminal region
and a catalytic domain at the C-terminal region.
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DUSP1, as the archetypal member of the family, has been
extensively studied. It is encoded by an immediate-early gene that
was first discovered in 1985 as one of the genes expressed in
cultured murine cells during the G0/G1 transition [24]. Since
DUSP1 knock-out (KO) mice were healthy and presented no
obvious phenotype related to MAPK activity [25], it was not until
the last decade that DUSP1 grew in importance due to the novel
phenotype of DUSP1 KO mice found after treatment with
corticoids. DUSP1 is ubiquitously expressed in the organism and it
is known to bind p38MAPK, JNK or ERK depending on the cell
status [26], [27]. DUSP1 expression is strongly upregulated upon
several stimuli such as oxidative stress, hypoxia, growth factors,
glucocorticoids, heat shock and UV [28], [29], [30], [31], [32].
DUSP1 is tightly regulated at transcriptional, translational and
post-translational levels. Some well-characterized examples are the
phosphorylation of Serines 359 and 364, which enhances the half-
life of DUSP1 [33] or the acetylation of DUSP1 that mediates
important events on the host inflammatory response [34], [35]. As
an important MAPK regulator, DUSP1 is involved in a wide
variety of cellular processes such as obesity, transplantation,
cancer, depressive behavior and inflammation [36], [37], [38],
[39], [40].
By microarray analysis of VACV-infected cells, we [41], [42]
and others [43], [44] have identified DUSP1 as one of the genes
specifically induced by VACV infection. Although several reports
have highlighted the importance of DUSP1 in parasite and
bacterial diseases [45], [46], [47], there is limited information on
the involvement of DUSP1 in viral infections. The present study is
focused on the role of DUSP1 in VACV infection and more
specifically in the replication of wild-type (WT) VACV Western
Reserve (WR) and VACV attenuated viruses Modified Vaccinia
virus Ankara (MVA) and NYVAC. We have addressed this issue
both in vitro, by using cultured DUSP1 WT and KO cells, siRNA
technology and nucleofection, and in vivo through a DUSP1 KO
mouse model. We showed that replication of WR and MVA is
enhanced in the absence of DUSP1 and that, interestingly,
DUSP1 is a key factor during MVA morphogenesis in murine
cells. Moreover, we demonstrated the influence of DUSP1 in host
innate and adaptive immune responses elicited by VACV. Overall,
the present study reveals a novel role for DUSP1 in VACV
infection and provides new insights into the still not fully
understood MVA host restriction process.
Materials and Methods
Ethics statement
Animal experimental protocols were approved by the Ethical
Committee of Animal Experimentation (CEEA-CNB) of Centro
Nacional de Biotecnologia (CNB-CSIC, Madrid, Spain) in strict
accordance with Spanish national Royal Decree (RD 1201/2005)
and international EU guidelines 2010/63/UE about protection of
animals used for experimentation and other scientific purposes and
Spanish national law 32/2007 about animal welfare in their
exploitation, transport and sacrifice and also in accordance with
the Royal Decree (RD 1201/2005). Permit numbers: 10-018 and
10-023.
Cells and viruses
African green monkey kidney cells (BSC40) from ATCC were
grown in Dulbecco’s Modified Eagle’s medium (DMEM) with
penicillin (100 U/ml, Invitrogen), streptomycin (100 mg/ml, In-
vitrogen), L-glutamine (2 mM; Merck) and supplemented with
10% newborn calf serum (NCS; Sigma). Human HeLa cells
(human cervix adenocarcinoma cell line), baby hamster kidney
cells (BHK-21), DF-1 (a spontaneously immortalized chicken
embryo fibroblast cell line), all from ATCC, and DUSP1 wild-type
and knock-out murine embryonic fibroblasts were cultured in
complete DMEM supplemented with 10% fetal calf serum (FCS;
Sigma). Cells were maintained in a humidified air-5% CO2
atmosphere at 37uC or 39uC (for DF-1 cell line). VACV wild-type
Western Reserve (WR) was grown in monkey BSC40 cells and
purified by sucrose gradient banding. NYVAC (kindly provided by
Sanofi-Pasteur) and MVA (kindly provided by G. Sutter) were
grown in BSC40 cells and in BHK-21 cells, respectively, and
purified by two subsequent 36% sucrose (w/v) cushions. After all
infections, complete DMEM supplemented with 2% NCS or FCS
was added to the cultured cells. WR, MVA and NYVAC were
titrated in DF-1 cells by immunostaining plaque assay as
previously described [48]. Where indicated, purified WR was
inactivated by ultraviolet light during 20 min [49].
Quantitative Real-Time RT-PCR
HeLa cells were mock-infected or infected with WR, MVA or
NYVAC at 5 PFU/cell. Where indicated, cells were infected in
the presence of Cycloheximide (CHX) at a final concentration of
100 mg/ml. Total RNA was isolated using RNeasy Mini kit
(Qiagen) following manufacturer’s instructions. Total RNA (1 mg)
was digested with DNases to avoid genomic DNA contamination.
Reverse-transcription PCR (RT-PCR) was performed using
Superscript first-strand synthesis system (Invitrogen). 50 ng of
cDNA was assayed for human DUSP1 expression using specific
Taqman probes (Applied Byiosystems) and TaqMan Universal
PCR MasterMix (No AmpErase UNG). Duplicates were assayed
for each sample. Data were acquired with an ABI PRISM 7000
sequence detection system and analyzed with ABI PRISM 7000
SDS version 1.2.3 software (Applied Biosystems).
Protein analysis by immunoblotting
Cells were infected with WR, MVA or NYVAC at 5 PFU/cell,
harvested at different times post-infection and protein extracts
obtained using lysis buffer following manufacturer’s recommen-
Author Summary
Phosphorylation is a post-translational modification that is
highly conserved throughout the animal kingdom. Viruses
have evolved to acquire their own kinases and phospha-
tases and to be able to modulate host phosphorylation
mechanisms on their benefit. DUSP1 is an early induced
gene that belongs to the superfamily of Dual-specificity
phosphatases and provides an essential negative feedback
regulation of MAPKs. DUSP1 is involved in innate and
adaptive immune responses against different bacteria and
parasites infections. The use of Knock-out technology has
allowed us to understand the role of DUSP1 in the context
of VACV infection both in cultured cells and in the in vivo
mouse model. Here, we have showed that DUSP1
expression is upregulated during VACV infection and that
DUSP1 plays an important role in VACV replication.
Interestingly, we have demonstrated that the VACV
attenuated virus MVA is able to grow in immortalized
murine embryo fibroblasts in the absence of DUSP1. In vivo
results showed that VACV replication-competent WR
pathogenesis is enhanced in the absence of DUSP1.
Furthermore, we have demonstrated that DUSP1 is
involved in the host innate and adaptive responses against
VACV. Altogether, we have presented a novel role for
DUSP1 in VACV replication and anti-VACV host immune
response.
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dations (Cell lysis Buffer, Cell Signaling). Equal amounts of protein
(50 mg) were fractionated by 10% SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and then transferred to nitrocellulose
membrane (Bio-Rad Laboratories) in a wet blotting apparatus
(Bio-Rad) for 50 min. Membranes were blocked with TBS-Tween
20 0,1% BSA 5% and then incubated with specific antibodies
against viral proteins such as E3 (kindly provided by B. Jacobs),
A10 and L4R (kindly provided by D. Hruby), A14 (CNB, CSIC),
A17 (CNB, CSIC), A17-N (kindly provided by J. Locker) and A17-
C (CNB, CSIC) or cellular proteins such as a-tubulin, P-DUSP1,
P-ERK1/2 and P-JNK (Cell Signaling) or total DUSP1 (Santa
Cruz Biotechnology), ERK1/2 or JNK (Cell Signaling). The anti-
rabbit-HRPO (Sigma) was used as secondary antibody and the
immunocomplexes were detected by enhanced chemilumines-
cence (ECL, GE Healthcare). The viral DNA synthesis inhibitor
Arabinofuranosyl Cytidine (Ara-C) and protein synthesis inhibitor
CHX from (SIGMA) were added to cell culture media at 40 mg/
ml and 100 mg/ml, respectively.
Analysis of viral growth
To determine viral growth profiles, duplicate samples of
monolayers of MEFs grown in 12-well tissue culture plates were
infected at 0.01 PFU/cell with WR, MVA or NYVAC. At 0, 24
and 48 hours post-infection, samples were collected and titrated as
described previously [6]. Specific MAPKs inhibitors, ERK
inhibitor UO126 (Cell Signaling) and p38MAPK inhibitor
SB203580 (Calbiochem), were added to the cell culture at a
concentration of 10 or 50 mM and 5 mM, respectively, for 30 min
or 1–8 h (UO126) or 30 min (SB203580) before the infection.
Alternatively to KO cells, DUSP1 expression was suppressed
with interference RNAs. Duplicate samples of subconfluent
monolayers of HeLa cells grown in 12-well tissue culture plates
were treated with DUSP1 specific siRNAs (siGENOME
SMARTpool, Dharmacon; target sequence 1: CCAUUGUCC-
CAACCAUUU; target sequence 2: CAACGAGGCCAUUGA-
CUUC; target sequence 3: CCACCACCGUGUUCAACUUÇ;
target sequence 4: GCAUAACUGCCUUGAUCAA) or Scram-
ble siRNA (Applied Biosystems) as a control, at a final
concentration of 50 nM using Lipofectamine 2000 (Invitrogen).
After 48 hours of incubation with the siRNAs, cells were
infected with WR or MVA at 0.1 PFU/cell. At 0, 24 and
48 hours post-infection cells in medium were collected and virus
titrated as previously described [6].
Nucleofection assay
DUSP1 KO MEFs were nucleofected using 4D-Nucleofector
(Lonza) and Amaxa P3 Primary Cell kit (Lonza) following
manufacturer’s instructions. Briefly, 26106 cells were resuspended
in 100 ml P3 Buffer Mix and nucleofected with 6 mg of pSG5-
DUSP1 plasmid (kindly provided by E. Perdiguero) or pSG5-
empty plasmid as a control. After 24 hours of incubation, MEFs
were infected with WR or MVA at 0.1 PFU/cell and viral titers
were determined at 0, 24 and 48 hpi by immunoplaque assay in
DF-1 cells.
Immunofluorescence
MEFs were infected with WR, MVA or NYVAC at 5 PFU/cell
and at 5.5 or 16 hpi. Cells were fixed with 4% paraformaldehyde
(PFA) and permeabilized with 0.05% saponin in 2% FCS-
supplemented phosphate-buffered saline (PBS). Specific antibodies
against viral proteins A27 (1:2000), A17 and A14 (1:1.000) were
used (CNB). Bound primary antibodies were detected with
AlexaFluor-488 or 2594 conjugated antibodies specific for mouse
or rabbit (Invitrogen 1:500). b-Actin was detected with a TRITC-
conjugated probe anti-Phalloidin (Sigma, 1:500). Cell nucleus was
stained with 49, 6-diamino-2-phenylindole (DAPI; Sigma, 1:200).
To block DUSP1 in WT cells, siRNA treatment was performed on
subconfluent monolayers of MEFs using Lipofectamine 2000
(Invitrogen) as transfection agent and a mix of two DUSP1 specific
siRNAs (Applied Biosystems) at a final concentration of 100 nM.
After 24 hours of incubation, cells were infected with VACV and
specific viral proteins were detected by immunofluorescence and
confocal microscopy as described above.
Electron microscopy
Confluent monolayers of MEFs were mock-infected or infected
with MVA at 5 PFU/cell and at 16 hpi cells were fixed for
2 hours with 4% PFA+2% glutaraldehyde in NaH2PO4/
Na2HPO4 0.1M pH 7.4 buffer. Samples were then washed (3
times, 10 min each) with NaH2PO4 pH 7.4 buffer, scrapped and
harvested in 1.5 ml of the same buffer. Fixed samples were
processed by conventional embedding in the epoxi-resin EM-812
(Taab Laboratories, Adermaston, Berkshire, UK). Ultrathin
sections of 70 nm thick were collected on formvar-coated
parallel-bar copper grids and analyzed with a JEOL 1011
transmission electron microscope. Quantitative analysis of viral
forms by electron microscopy was performed analyzing 30 infected
cells per cell line (DUSP1 WT and KO cells). The results represent
the percentage of each viral intermediate in the total of viral
particles quantified.
Mice, viral inoculation, pathogenicity analysis and sample
collection
DUSP1 KO mice were generated by Jackson laboratories using
embryos with a 129S2/SvPas genetic background. Jackson Labs
provided Dr. Caelles lab with the resulting mice and they were
backcrossed in a C57BL/6 background for at least 11 mice
generations. MEFs from wild type and KO mice were generated
independently from mouse embryos by Caelle’s and Esteban’s labs
following standard procedures.
Groups of 8–10 week-old DUSP1 WT or KO mice were
intranasally (i.n., n = 5, 20 ml inoculum), intraperitoneally (i.p.,
n = 3–4, 200 ml inoculum) inoculated or skin scarified (s.s., n = 3–4,
10 ml inoculum) with different challenge doses of WR (56105–
56106 PFU/mouse), MVA or NYVAC (56106–26107 PFU/
mouse). Representative examples of three independent experi-
ments are shown in the figures. Weight loss, mortality and signs of
illness, such as reduced mobility and ruffled fur, were daily
evaluated using a 0–3 scale (healthy-ill). For in vivo viral replication
assays, mice were sacrificed at various times post-inoculation and
spleen, liver, ovaries (i.p.), lungs (i.n.) or tail tissue (s.s.) were
excised, washed with sterile PBS and stored at 270uC. Tissue
extracts were obtained by homogenizing representative sections of
each tissue. Homogenized samples were subjected to three cycles
of freezing and thawing, sonicated and centrifuged (10 min/
2000 rpm); supernatants were collected and titrated by immuno-
staining plaque assay. Serum was obtained by submaximal vein
bleedings 3 or 24 hours post-inoculation and was allowed to clot
1 hour at 37uC. After a 4uC overnight incubation, they were spun
down in a microcentrifuge, serum was collected, aliquots were
prepared, pooled and stored at 220uC.
Cytokine analysis
Sera from mock-infected or WR, MVA or NYVAC-infected
mice were assayed for detection of IL-6, TNF-a, IL-1b and IL-10
using LUMINEX technology according to the manufacturer’s
instructions. All samples were kept at 220uC until use.
DUSP1 and Vaccinia Virus Infection
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Measurement of luciferase activity
Recombinant viruses WR-Luc, MVA-Luc and NYVAC-Luc
expressing luciferase have been previously described [50], [51].
Samples from mice i.p. inoculated with these viruses at
26107 PFU/mouse were homogenized in 200–400 ml of luciferase
assay reagent (Promega) per sample. Clarified supernatants were
used to measure luciferase activity in the presence of luciferine and
ATP according to the manufacturer’s instructions, using Lumit LB
9501 luminometer (Berthold). The luciferase activity is represented
as luciferase units per miligram of protein (U/mg).
Intracellular cytokine staining (ICS)
The specific VACV-induced T cell response was analyzed by
ICS and flow cytometry fluorescence-activated cell sorting analysis
(FACS). After isolation of splenocytes from infected mice, samples
were resuspended in RPMI 1640 supplemented with 10% FCS
and containing 1 mg/ml Golgiplug (BD Biosciences) to inhibit
cytokine secretion. Cells were stimulated with E3 peptide
(sequence: VGPSNSPTF, CNB, CSIC) added to the cells at a
final concentration of 5 mg/ml. After 6 hours of incubation at
37uC and 5% CO2, cells were washed, fixed, permeabilized, using
the BD Cytofix/Cytoperm Kit (Becton Dickinson), and stained
intracellularly using the appropriate fluorochrome-conjugated
antibodies. To analyze the adaptive immune responses, the
following fluorochrome-conjugated antibodies were used: CD3-
FITC or -PerCP, CD4-Alexa 700 or –APCCy7, CD8-PerCP or –
V500, IL-2-PE or –PE-Cy7, IFN-c-APC or –PE-Cy7 and TNF-a-
PE-Cy7 or -PE. All antibodies were from BD Biosciences. Cells
were acquired using an LSRII flow cytometer (Becton Dickinson).
Dead cells were excluded using the violet LIVE/DEAD stain kit
(Invitrogen). Lymphocytes were gated on a forward scatter area
versus side scatter area pseudo-color dot plot. To analyze the
adaptive immune responses, CD4+ and CD8+ T cells (previously
gated on CD3+ cells) were gated versus IFN-c, TNF-a and IL-2
and then combined together using the boolean operator. Sample
analysis was performed using FlowJo version 8.5.3 (Tree Star,
Ashland, OR).
Data analysis and statistics
For the statistical analysis of the viral growth and the differences
between groups of mice a Student T test was performed. Statistical
significance is represented as p,0.05 (*), p,0.005 (**) or p,0.001
(***).
For the statistical analysis of ICS data, we used a novel
approach that corrects measurements for the medium response
(RPMI) and calculates confidence intervals and p values of
hypothesis tests [52], [53]. Only antigen responses values
significantly higher than the corresponding RPMI are represented
and the background for the different cytokines in the unstimulated
controls never exceeded 0.05%. We used the data analysis
program Simplified Presentation of Incredibly Complex Evalua-
tions (SPICE, version 4.1.5, Mario Roederer, Vaccine Research
Center, NIAID, NIH) to analyze and generate graphical
representations of T cell responses detected by polychromatic
flow cytometry. All values used for analyzing proportionate
representation of responses are background-subtracted.
Accession numbers
- Tubulin: human, P68366, UniprotKB.
- DUSP1: human, P28562, UniprotKB.
- DUSP1: mouse, P2563, UniprotKB.
- ERK1: mouse, Q63844, UniprotKB.
- ERK2: mouse, P63085, UniprotKB.
- JNK1: mouse, Q01Y86, UniprotKB.
- JNK2: mouse, Q9WTU6, UniprotKB.
- p38MAPK: mouse, P47811, UniprotKB.
- IFN-c: mouse, P01580, UniprotKB.
- IL2: mouse, P04351, UniprotKB.
- TNF-a: mouse, P06804, UniprotKB.
- IL6: mouse, P08505, UniprotKB.
- IL1b: mouse, P10749, UniprotKB.
- IL10: mouse, P18893, UniprotB.
Results
DUSP1 expression is upregulated upon VACV infection
We and others have previously described using microarray
technology that DUSP1 mRNA transcription is specifically
upregulated during VACV infection [42], [43], [44], [42]. To
validate these previous observations, we carried out RT-PCR and
Western-blot analyses from HeLa cells infected with the virulent
WR strain or with the attenuated VACV mutants MVA and
NYVAC. As shown by RT-PCR, in HeLa cells infected with WR,
MVA or NYVAC, there was an increase in DUSP1 mRNA levels
at the different times post-infection analyzed (Fig. 1A). The
induction was more pronounced at 6 hpi, especially for NYVAC
infection. The increase in DUSP1 protein expression levels
following VACV infection was confirmed by Western-blot analysis
(Fig. 1B). DUSP1 protein was upregulated during the infection
with each one of the three viruses used and this increase peaked
between 4 and 6 hpi. The highest levels of DUSP1 induction were
observed upon NYVAC infection where an increase in protein
expression was still detected at 8 hpi. This upregulation was
VACV-specific since in uninfected control cells DUSP1 protein
level was below the limit of WB detection.
To determine if VACV not only triggers enhanced protein
synthesis but also affects protein stability, we used an antibody that
recognizes specifically phosphorylated serines 359 and 364, which
are the residues responsible for DUSP1 stabilization [33]. We
observed phosphorylation of DUSP1 after the infection with each
one of the three viruses used. The highest phosphorylation levels of
DUSP1 were observed at 4 hpi (Fig. 1B). The findings of Fig. 1
showed that DUSP1 mRNA transcription and DUSP1 protein
expression as well as DUSP1 phosphorylation were specifically
modulated by VACV infection in HeLa cells.
DUSP1 protein induction and phosphorylation require
early VACV protein synthesis and ERK activation
To define the role of viral proteins on DUSP1 induction, we
treated HeLa cells with a UV-inactivated WR virus which is
unable to synthesize viral RNA or protein or with an inhibitor of
viral DNA synthesis, Arabinofuranosyl Cytidine (Ara-C). In the
presence of Ara-C (Fig. 2A, central panel), early VACV proteins,
such as E3 (p25), were expressed, however, late viral proteins such
as A17 (p17) were not produced. In Ara-C-treated samples,
DUSP1 expression showed the same kinetics as observed in WR-
infected cells (Fig. 2A, left panel), whereas DUSP1 induction was
not observed in UV-inactivated WR-infected cells (Fig. 2A, right
panel) nor with a 55uC inactivated WR (not shown). These
findings reveal that early but not late viral gene expression is
required for VACV-mediated DUSP1 protein upregulation.
To define which viral component is responsible for the
induction of DUSP1 mRNA, we infected HeLa cells with WR
in the presence of CHX, which allows viral mRNA but not protein
synthesis, and determined the levels of DUSP1 mRNA by
quantitative RT-PCR. As shown in Fig. 2B (left panel), in the
presence of CHX there was an increase of DUSP1 mRNA levels
DUSP1 and Vaccinia Virus Infection
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in comparison with untreated infected samples, indicating that
DUSP1 mRNA expression is dependent on viral RNA synthesis.
In order to analyze whether this result could also be observed with
an attenuated VACV and to test another cell culture model, we
infected DUSP1 WT MEFs with MVA and analyzed DUSP1
mRNA. Fig. 2B (right panel) shows for MVA in MEFs similar
kinetics for DUSP1 mRNA to HeLa cells.
In order to determine whether during VACV infection DUSP1
stabilization is mediated by ERK phosphorylation or other cellular
kinase or if a viral-encoded kinase is involved, we used an ERK
inhibitor (UO126). ERK inhibitor was added to the culture
medium 30 min before infection and was present in the cell
culture at all times during infection. In the presence of ERK
inhibitor (Fig. 2C), ERK phosphorylation and, consequently ERK
activation, was completely abrogated and we could not detect
DUSP1 phosphorylation.
The findings of Figure 2 reveal that induction of DUSP1
mRNA and protein required viral mRNA synthesis and early viral
gene expression. Moreover, DUSP1 phosphorylation during
VACV infection is mediated by ERK.
DUSP1 modulates VACV replication in cultured cells
DUSP1 plays an important role in the negative regulation of
MAPKs upon different stimuli, including bacteria and parasite
infections [54]. Nevertheless, little is known about the function of
DUSP1 in viral infections. To assess this issue, we decided to
determine the effect of the absence of DUSP1 on the replication of
WR, MVA or NYVAC. We observed a significant increase
(24 hpi: p,0.05; 48 and 72 hpi: p,0.005) in WR replication in
KO MEFs in comparison with WT MEFs (Fig. 3A). Surprisingly,
when we infected the cells with MVA, which also cannot replicate
in most mammalian cell lines, we detected higher viral titers in
KO MEFs in comparison with the WT MEFs; this significant
difference (24 and 48 hpi: p,0.05; 72 hpi: p,0.005) in replication
of about two logs higher was evident at 24 hpi and increased with
time (Fig. 3B). Productive MVA infection required DUSP1 KO
MEF immortalization process, as MVA produced abortive
infections in primary DUSP1 KO MEFs obtained from DUSP1
KO mice (data not shown). However, we could not detect
NYVAC replication in KO nor in WT MEFs (Fig. 3C), which was
consistent with the fact that NYVAC is unable to replicate in
murine cell lines.
In order to further confirm these results, we treated HeLa cells,
which is a permissive cell line for WR but host-restricted to MVA
replication, with specific siRNA to suppress DUSP1 expression. As
shown in Fig. 4A, DUSP1 mRNA expression was efficiently
suppressed (lower panel) and viral titers of both WR and MVA
were significantly increased (upper and middle panels) (WR,
24 hpi: p,0.05; MVA, 48 hpi: p,0.001) in HeLa cells treated
with DUSP1 siRNAs compared to cells treated with a scramble
siRNA. This phenotype mimics what it was that previously
observed in DUSP1 KO cells infected with either WR or MVA
(Fig. 3).
In addition, to further prove the role of DUSP1 in VACV
replication, we nucleofected a DNA vector expressing DUSP1
gene into DUSP1 KO MEFS, then cells were infected with WR or
MVA and viral titers were determined at 0, 24 and 48 hpi. As
shown in Fig. 4B, DUSP1 expression was successfully restored into
KO MEFs (WB in lower panel) and viral titers were significantly
(MVA, 48 hpi: p,0.05) reduced in cells infected with MVA
expressing DUSP1 (middle panel) in comparison with control cells.
This effect was not observed in the case of WR infection (upper
panel).
The results of Fig. 4 establish that DUSP1 plays a role in the
replication of VACV, and this effect is more prevalent in the case
of the MVA strain.
Figure 1. DUSP1 expression is upregulated upon VACV
infection. A) DUSP1 mRNA levels after VACV infection. HeLa cells
were infected with WR, MVA or NYVAC at a MOI of 5 and samples from
2, 6 and 16 hours post-infection were assayed by RT-PCR. B) DUSP1
protein levels after VACV infection. HeLa cells were mock-infected or
infected as in A) and equal amounts of protein from cell extracts were
analyzed by Western Blot using specific antibodies against DUSP1, P-
DUSP1 or tubulin.
doi:10.1371/journal.ppat.1003719.g001
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Figure 2. DUSP1 induction and phosphorylation requires early VACV gene expression and ERK activation. A) DUSP1 protein levels
after WR infection. HeLa cells with were treated with Ara-C (40 mg/ml) or left untreated and then subsequently mock-infected, infected with UV-
inactivated WR or infected with WR at 5 PFU/cell. Equal amounts of proteins were analyzed by Western-blot using specific antibodies against DUSP1
or tubulin or viral proteins such as E3, A4 and A17. Lower graph represents fold increase of DUSP1 mRNA of CHX-treated WR-infected HeLa cells
versus untreated WR-infected cells. mRNA levels are represented in Arbitrary Units. B) DUSP1 mRNA levels after VACV infection. HeLa cells or DUSP1
WT MEFs were treated with CHX (100 mg/ml) or left untreated and then subsequently infected at 5 PFU/cell with WR or MVA, respectively. Graphs
represent fold increase of DUSP1 mRNA of CHX-treated infected cells versus untreated infected cells. mRNA levels determined by qRT-PCR are
represented in Arbitrary Units. C) DUSP1 phosphorylation after WR infection. HeLa cells were treated with ERK inhibitor UO126 (50 mM/8 h) or left
untreated and the infected as in A). Cells extracts were analyzed by Western-blot using antibodies against DUSP1, P-DUSP1, ERK, P-ERK or tubulin.
p,0.05 (*), p,0.005 (**) and p,0.001 (***).
doi:10.1371/journal.ppat.1003719.g002
DUSP1 and Vaccinia Virus Infection
PLOS Pathogens | www.plospathogens.org 6 November 2013 | Volume 9 | Issue 11 | e1003719
Figure 3. DUSP1 modulates VACV replication in cultured cells. DUSP1 WT and KO MEFs were infected at 0.01 PFU/cell with WR (A), MVA (B) or
NYVAC (C). Samples were collected at 0, 24, 48 and 72 hours post-infection and viral titers were determined by immunostaining plaque assay in DF1 cell
line. One representative example of three independent experiments assayed in duplicate is represented. p,0.05 (*), p,0.005 (**) and p,0.001 (***).
doi:10.1371/journal.ppat.1003719.g003
DUSP1 and Vaccinia Virus Infection
PLOS Pathogens | www.plospathogens.org 7 November 2013 | Volume 9 | Issue 11 | e1003719
Figure 4. The increased VACV replication in cultured cells is DUSP1 specific. A) HeLa cells were treated with 50 nM of either DUSP1 siRNAs
or scramble siRNA as a control and after 24 hours of incubation cells were infected with WR or MVA at 0.1 PFU/cell. Samples were collected at 0, 24
and 48 hours and viral titers were determined by immunostaining plaque assay in DF-1 cell line. Lower panel shows fold decrease of DUSP1 mRNA
levels in siRNA-treated cells compared to mRNA levels in scramble siRNA-treated cells. B) DUSP1 KO MEFs were nucleofected with 6 mg of either
pSG5-empty or pSG5-DUSP1 and DUSP1 protein expression analyzed by WB at 24 and 48 hours post-transfection (lower panel). After 24 hours of
incubation with siRNAs, cells were infected with WR or MVA at 0.1 PFU/cell. Samples were collected at 0, 24 and 48 hours and viral titers were
determined as in A. One representative example of two independent experiments assayed in duplicate is represented. p,0.05 (*), p,0.005 (**) and
p,0.001 (***).
doi:10.1371/journal.ppat.1003719.g004
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DUSP1 is responsible for the host restriction of MVA in
MEFs
To further characterize the role of DUSP1 in MVA replication
in MEFs, we performed a viral growth assay to evaluate the levels
of cell-associated virus and released virus from infected cells. The
titration of cell-associated virus showed a difference of over 2 logs
in MVA production between KO and WT cells (Fig. 5A). This
difference was even more evident in the case of released virus since
we could not detect the presence of virus in the cell supernatants of
WT-infected MEFs. Moreover, when we performed immunopla-
que assay of MVA-infected WT or KO MEFs, we could only
observe virus plaques in the absence of DUSP1 at any time point
analyzed (Fig. 5B). There were differences in the cytopathic effect
(CPE) produced by MVA infection between WT and KO cells
(Fig. 5C), with a more pronounced CPE in KO MEFs (lower
panels) compared to WT MEFs (upper panels). Altogether, these
results reveal a distinct behavior of MVA in KO MEFS in
comparison with WT MEFs indicating that the host restriction of
MVA replication in murine cells is overcome in the absence of
DUSP1.
DUSP1 acts in the transition between immature to
mature viral forms of MVA
Considering our previous data showing that MVA was able to
complete its viral cycle in MEFs in the absence of DUSP1, we next
wanted to determine which of the events blocked during MVA
morphogenesis is overcome by the action of DUSP1. To address
this issue, we studied early, intermediate and late events during
MVA morphogenetic process in the absence of DUSP1.
First, we analyzed by immunofluorescence and confocal
microscopy the expression of the viral membrane proteins A14
(p16) and A17 (p17), which play key roles during the formation of
crescents [55], [56]. In DUSP1 WT and KO MEFs infected with
WR, MVA or NYVAC at 5 PFU/cell (Fig. 6A), we did not
observe differences in the expression pattern of A14 or A17
between WT and KO MEFs. Black panels in Fig. 6A showed a
punctuated pattern of both A14 and A17 in MVA-infected cells
that localized with viral factories. Since the pattern of localization
of A14 and A17 was similar in WT and KO-infected cells, we can
suggest that this step of viral morphogenesis is not dependent on
DUSP1.
During VACV morphogenesis, the processing of viral mem-
brane and core proteins is required prior to formation of the
mature virion. Some of the proteins that need proteolytic cleavage
during infection are A10 (p4a), L4 (p25K) and A17 (p17). In order
to analyze this event, we infected WT and KO cells with WR,
MVA or NYVAC and determined the expression of these three
viral proteins at 2, 6, 16 and 24 hours post-infection by Western-
blot analysis using antibodies that recognize the processed forms of
the proteins: 4a, 25K, A17-C (processed C-terminus) and A17-N
(unprocessed N-terminus) (Fig. 6B). In the case of WR and MVA,
processed forms of these proteins were found in both WT and
KO-infected cells. However, as observed in the right panel, we
could not detect any of these proteins in WT or KO cells infected
with NYVAC, consistently with previous reports demonstrating
that NYVAC does not produce certain late viral proteins in non-
permissive cells lines [6]. These findings reveal that DUSP1 is not
involved in proteolytic processing of viral proteins during the
maturation of MVA progeny particles.
To examine a later event in morphogenesis, we analyzed by
immunofluorescence and confocal microscopy the distribution of
the late viral membrane protein A27 (p14). As shown in Fig. 6C, in
WT cells infected with MVA, a clear diffuse pattern of expression
of A27 across the cytoplasm of the infected cell was observed
indicating that A27 was expressed but it did not appear to be
incorporated into virions. In contrast, in MVA-infected DUSP1
KO MEFs (Fig. 6C, upper right panel), A27 showed both a diffuse
and a punctuated pattern (right-lower magnification) characteristic
of the labeling of mature virions. Similar punctuated pattern of
A27 was observed when DUSP1 expression was blocked in WT
MEFs with siRNAs and infected with MVA (data not shown).
These results suggest that DUSP1 might be involved in events that
occur before the formation of mature virions.
In order to identify the step of MVA morphogenesis affected by
DUSP1, we performed electron microscopy analysis of DUSP1
WT and KO MEFs infected with MVA for 16 h at 5 PFU/cell.
Figures 7A–C showed the most characteristic viral forms present
in MVA-infected WT cells represented by small and medium
viroplasm foci (V) surrounded by nascent crescents (C), immature
virus (IV) and immature virus with nucleoid (IVN). In addition,
there were also several transition forms from IVN to mature virus
(MV) as electro-dense particles being wrapped by a membrane
(Fig. 7D). These occasional intermediate forms have also been
described during infection of HeLa cells with MVA [57]. Aberrant
viral forms with multiple wrappings (onion-like particles, Fig. 7E)
were also observed as well as virions with impaired nucleoid
formation (Fig. 7F) and MV-like particles without a proper core
condensation (Fig. 7G). In the case of DUSP1 KO cells infected
with MVA, we detected all the classical viral forms, from
viroplasm foci (V) with crescents, IV, IVN, MV, wrapped virus
(WV) and enveloped virus (EV) (Figs. 7H–O). Groups of MV
within a membrane were also observed (Fig. 7L). To further
characterize MVA outcome in WT and KO infected cells, we
quantified the percentages of the different viral forms by counting
sections of 30 cells from each cell line (Fig. 7P). In MVA-infected
WT cells, IV (80%) and IVN (16%) were the most abundant viral
forms. The percentages of the different viral forms detected in
MVA-infected DUSP1 KO cells were remarkably different with
59% of IV and almost the same amount (14%) of IVN compared
to WT-infected cells, whereas MV accounted for 20%, a
percentage equivalent to VACV outcome in a permissive cell line
[56]. In addition, we were able to detect the presence of WV (4%)
and EV (2%). The analysis by electron microscopy clearly showed
that in DUSP1 KO cells, MVA is able to complete the
morphogenesis process suggesting that DUSP1 is mainly acting
at the stage of transition between IVN and MV.
Activation of MAPKs contributes to the replication of
MVA in DUSP1 KO MEFs
Since DUSP1 is an important MAPK regulator and VACV
infection is able to trigger or block specific molecules of this
pathway such as ERK, p38MAPK and JNK [58], [59], [60], we
next determined the effect of the absence of DUSP1 in the
activation of these kinases during VACV infection. To address this
issue, we infected DUSP1 WT and KO MEFs with WR, MVA or
Figure 5. DUSP1 is responsible for the host restriction of MVA in MEFs. A) Viral growth of MVA in DUSP1 WT and KO cells infected at
0.01 PFU/cell. Samples of released and cell-associated virus were collected at 0, 24, 48 and 72 hours post-infection and viral titers were determined by
immunostaining plaque assay in DF-1 cells. B) Immunostaining plaque assay of MVA infection in DUSP1 WT and KO cells infected as in A. C)
Cytopathic effect observed in DUSP1 WT and KO cells infected with MVA as in A. p,0.05 (*), p,0.005 (**) and p,0.001 (***).
doi:10.1371/journal.ppat.1003719.g005
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NYVAC at 5 PFU/cell and analyzed the expression of these
proteins by Western-blot at 0.25, 0.5, 1, 2, 4, 6 and 8 hours post-
infection. As shown in Fig. 8A, the three viruses triggered
phosphorylation of ERK as early as 15 min post-infection. In the
case of WT-infected MEFs (left columns), a modest phosphory-
lation of ERK was observed, while this activation was dramatically
enhanced in the absence of DUSP1 (right columns). In KO-
infected MEFs, ERK phosphorylation peaked between 2 and
4 hpi and this activation was maintained along the time course
analyzed. We also observed that VACV infection preferentially
phosphorylated ERK-2 in MEFs. A similar pattern of activation
was observed in the case of JNK, although in this case we could
not detect activation at early times post-infection. In KO MEFs
infected with WR, MVA or NYVAC, JNK phosphorylation was
markedly enhanced after 2 hours post-infection, while low levels of
phosphorylation were detected in WT MEFs infected with any
virus.
Altered activation of MAPKs during viral infection in the
absence of DUSP1 might be the cause of the differences observed
in VACV host range and replication. In order to analyze the
specific contribution of each MAPK in the replication of MVA in
DUSP1 KO-infected MEFs, we used MAPK inhibitors UO126
and SB203580 to block ERK and p38MAPK, respectively. The
JNK inhibitor SP600125 could not be used because it has been
recently described to exert anti-poxviral effects independent of its
JNK inhibitory activity [61].
The MAPKs inhibitors were added to DUSP1 KO cells,
previously infected with MVA, at 0, 1 or 3 hours post-infection
and 24 hours later viral titers were determined. We observed
about 2 to 5-fold decrease in MVA replication in DUSP1 KO-
infected cells treated with the inhibitors in comparison with mock-
treated KO-infected cells (Fig. 8B). From these findings, we
conclude that activation of MAPKs by virus infection contributes
to the replication of MVA in DUSP1 KO cells.
DUSP1 KO mice are more susceptible to WR infection
than WT mice
The role of DUSP1 in bacterial and parasite diseases and
clearance by the host has been well described [53]. However, little
information has been reported regarding the involvement of
DUSP1 in viral infections. To determine the function of DUSP1
during VACV infection, we inoculated DUSP1 WT and KO mice
intranasally (i.n) with either 56105 or 56106 PFU/mouse of WR
and monitored mice for different signs of disease like weight loss,
illness (reduced mobility and ruffled fur) and mortality. DUSP1
KO mice experienced a significant (higher dose, day 3: p,0.005;
low dose, day 4: p,0.05) more accelerated weight loss than their
wild-type littermates during the course of the infection, with a
reduction of 25% (high dose) or 21% (low dose) at day 5 post-
infection (Fig. 9A). This susceptibility was also reflected by the
worse disease prognosis evaluated daily during infection (Fig. 9B).
Moreover, the onset of mortality of DUSP1 KO mice began as
soon as 4 days post-infection, with the death of 3 out of 5 mice and
reached the top at 6 days post-infection (Fig. 9C). In the case of
DUSP1 WT mice it was not until day 6 when the first animal died
and by the end of the experiment 20% were still alive (Fig. 9C).
The viral titers in the lungs of infected animals at days 2 and 5
post-infection were higher in DUSP1 KO infected mice in
comparison with WT mice at both times post-infection (Fig. S1).
Together, these results demonstrate that DUSP1 deficiency leads
to an enhanced susceptibility of mice to WR infection and this
susceptibility could be related with an enhanced viral replication in
the lungs.
In addition, we evaluated MVA and NYVAC infection of mice
in the absence of DUSP1 administered by different routes of
inoculation. By i.n route with a dose of 107 PFU/mouse, neither
DUSP1 WT nor KO mice infected with MVA or NYVAC
displayed any sign of illness during the time period analyzed.
Furthermore, we could not detect virus replication in the lungs of
infected animals (data not shown). Next, we analyzed by a systemic
i.p route with 26107 PFU/mouse the replication of MVA and
NYVAC recombinants expressing luciferase. We collected spleens,
lymph nodes, testis and peritoneal washes from infected animals at
4 and 16 hpi and evaluated luciferase activity as an index of viral
replication (Fig. S2). We did not find differences in luciferase gene
expression between WT and KO mice in the tissues analyzed,
neither at 4 nor at 16 hpi. Finally, we skin-scarified groups of
DUSP1 WT and KO mice with MVA (26107 PFU/mouse tail)
and after 8 days post-infection we observed that lesions in the tails
of KO mice were more severe than in their WT counterparts (Fig.
S3); these lesions were not observed in media or PBS-scarified KO
mice indicating that the inflammatory lesions were solely due to
the virus inoculum. After virus titration of tail tissue samples from
infected animals, we did not find evidence of MVA replication
(data not shown), suggesting that the more severe lesions observed
in DUSP1 KO mice were related to a host inflammatory response
triggered by MVA infection in the absence of DUSP1.
DUSP1 is involved in the regulation of innate and
adaptive immune responses during VACV infection
DUSP1 is known to be an essential regulator of the host
inflammatory response that controls the production of several
cytokines following different stimuli [40]. It has been well
established that the enhanced inflammatory response, triggered
by the hyper-phosphorylation of MAPK in the absence of DUSP1,
can even kill the host [62]. At present, little is known about the role
of DUSP1 in host immune responses during viral infections. To
further analyze this effect, we first focused on innate immune
responses triggered after systemic (i.p) infection of DUSP1 WT
and KO mice with 107 PFU/mouse of WR or 26107 PFU/mouse
of MVA or NYVAC. We determined production of IL-6, TNF-a,
IL-1b and IL-10 at 3 and 24 hpi in serum from infected mice.
These cytokines were selected since they are the most commonly
induced cytokines triggered by other stimuli in the absence of
DUSP1. As shown in Fig. S4, most of these cytokines were not or
poorly induced in WT and KO mice infected with WR. However,
infection with MVA or NYVAC induced the expression of IL-6,
TNF-a and IL-10, being this induction higher in KO mice.
Differences in levels and in temporal induction of these cytokines
were found between infections with MVA versus NYVAC in
Figure 6. DUSP1 is involved in steps occurring before mature virion formation. A) Confocal microscopy of DUSP1 WT and KO cells. Cells
were infected at 5 PFU/cell with either WR, MVA or NYVAC. Samples were fixed at 5 h 30 min and stained with antibodies against viral proteins A14
or A17 (green), or probes that detect phalloidin (red) and DNA (DAPI, blue). Black panels show representative images of WT and KO cells infected with
MVA. B) Western-blot analysis of DUSP1 WT and KO cells infected at 5 PFU/cell with either WR, MVA or NYVAC. Samples were collected at 2, 6, 16 and
24 hours post-infection and analyzed by Western-blot with antibodies against viral proteins A10, L4 and A17 and cellular protein tubulin. C) Confocal
microscopy of DUSP1 WT and KO cells infected with MVA at 5 PFU/cell and fixed at 16 hpi. Lower panels represent magnifications (56) of the
pictures above. Samples were stained with antibodies against viral protein A27 (green), phalloidin (actin, red) and DNA (DAPI, blue).
doi:10.1371/journal.ppat.1003719.g006
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DUSP1 KO mice, an expected finding since these two viruses
differ in the number of immunomodulatory genes present in their
genomes [6].
Next, we characterized T cell responses after VACV infection,
analyzing the pattern of cytokine secretion by intracellular
cytokine staining (ICS) from splenocytes stimulated with the
immunodominant VACV E3 peptide. DUSP1 WT and KO mice
were i.p. inoculated with WR (107 PFU/mouse), MVA or
NYVAC (26107 PFU/mouse) and animals sacrificed after 10
days post-infection. Alternatively, we inoculated mice by i.n. route
with WR (105 PFU/mouse), MVA or NYVAC (56107 PFU/
mouse). After stimulating splenocytes from infected animals with
the VACV-E3 peptide, we analyzed by ICS the production of
IFN-c, IL-2 and TNF-a. As shown in Fig. 10A, the magnitude of
E3-specific CD8 T cell response after i.p. inoculation, determined
as the percentages of IFN-c and/or IL2 and/or TNF-a CD8
secreting cells, was significantly higher (p,0.001) in DUSP1 KO
infected mice with the three viruses, although it was more
remarkable in infections with WR and NYVAC. The antigen-
specific immune response elicited by the three viruses by i.p.
inoculation was highly polyfunctional and mainly represented by
triple and double positive T cells for TNF-a and IFN-c with
significant differences (p,0.001) in the magnitude of those
populations between DUSP1 WT and KO mice infected with
WR or NYVAC but not with MVA (Fig. 10C). Infections by the
i.n. route revealed also significant differences (p,0.001) in the
magnitude (Fig. 10B) and polyfunctionality (Fig. 10D) of the E3-
specific CD8 T cell responses between the three viruses,
particularly for DUSP1 KO infected animals. In this case, the
polyfunctional profile was represented by double positive CD8 T
cells for IFN-c and TNF-a and single positive CD8 T cells for
IFN-c (Fig. 10D).
The findings of Figs. 10 and S4 reveal that DUSP1 is involved
in the regulation of innate and adaptive immune responses during
a poxvirus infection, as shown by differential behavior of WR,
MVA and NYVAC regarding cytokine production and by the
higher percentage of cytokine-secreting CD8+ T cells induced in
DUSP1 KO mice in comparison with WT animals.
Discussion
At present, little is known about the role of DUSP1 in viral
infections. Our study has addressed this issue by using the VACV
system in both cultured murine cells and in mice lacking DUSP1.
In particular, we have shown the importance of DUSP1 in VACV
infection, from viral replication and host range to host immune
responses. In cultured cells, we have demonstrated that VACV
specifically upregulates DUSP1 during infection and this induction
is dependent on early viral protein synthesis. The higher
upregulation of DUSP1 mRNA in cells infected in the presence
of CHX suggests that viral RNAs released by viral cores (as CHX
blocks uncoating but allows RNA synthesis) are responsible for
DUSP1 mRNA induction. Moreover, VACV infection triggers
DUSP1 phosphorylation through activation of ERK, discarding
the possibility of phosphorylation by a viral kinase and demon-
strating that VACV not only triggers DUSP1 upregulation but
also DUSP1 protein stabilization. These results are consistent with
previous reports, which showed that VACV promotes ERK
activation allowing an efficient viral replication in the infected cells
and successful viral progeny release [17], [59], [7].
Of relevance, we have observed an increase of VACV
replication in DUSP1 KO immortalized MEFs compared to
WT cells. Specifically, we have detected an increase in WR viral
titers but more interestingly, in MVA viral titers. In addition, we
have further confirmed this enhanced WR and MVA replication
in DUSP1 KO MEFs using specific siRNAs against DUSP1 in
WR or MVA infection in cells from different origin such as
HeLa cells, and also restoring DUSP1 expression in DUSP1
KO cells. Permissiveness to poxvirus replication is mostly
dependent on intracellular events after entering the cells, such
as several host protein kinase cascades that can mediate
subsequent viral replication events rather than on cell surface
receptors. For example, VACV can even enter non-permissive
cell lines as insect cells [63]. In addition, although many
poxviruses show strict species specificities, these can vary
markedly such that cells derived from species that are not
considered permissive hosts can sometimes be productively
infected in vitro [64]. Phosphorylation is an important event that
numerous viruses use during their replication process [65], [66].
In the context of this study, the absence of DUSP1 led to a
change in the host range of MVA. This result might be related
with the observed changes in the pattern of MAPK activation
during MVA infection in the absence of DUSP1. Therefore, we
analyzed whether the inactivation of ERK and p38MAPK by
specific inhibitors had an implication on MVA replication in
DUSP1 KO cells. We have observed a reduction in MVA viral
titers in comparison with untreated DUSP1 KO cells infected
with MVA, suggesting that these MAPKs are directly involved
in the phenotype observed in the absence of DUSP1. There are
several possible explanations for these results. First, MAPKs
may be acting over cellular ligands to promote their stabiliza-
tion, activation or changes in their subcellular localization.
Thus, the MAPK-mediated hyper-phosphorylation in the
absence of DUSP1 during MVA infection may be miss-
regulating these processes in a manner that MVA is able to
replicate in murine cells. Alternatively, this phenotype may be
due to MAPK action over viral phosphoproteins. VACV has
been widely reported to use phosphorylation as a mechanism to
regulate the activity of several viral proteins [67]. Most of them
are phosphorylated by VACV-encoded kinases B1 and F10
[14], [68] but others are phosphorylated by cellular kinases [67].
Many of these phosphoproteins have an important role during
VACV morphogenesis [69], [70], [71], [72]. Then, the
phosphorylation status of viral structural proteins may be
affected by the absence of DUSP1 during MVA infection and
this may have an effect on virus morphogenesis.
Figure 7. DUSP1 acts on the transition of immature and mature virion forms of MVA. DUSP1 WT and KO MEFs were infected with MVA at
5 PFU/cell, fixed at 16 hpi and processed by conventional embedding in a epoxy resin as described in Materials and Methods. A) Representative
general overview of DUSP1 WT MEFs infected with MVA. Viroplasm foci (V) surrounded by crescents (C) and immature virions (IV) are also observed
(left panel). B–C) DNA accumulations (arrows), sometimes delimited by membranes, and classical viral intermediate forms such as IV and IV with a
nucleoid (IVN) are also observed. *Viral genome entering IV. D, E) Occasionally IVN-MV transition forms (arrowheads) are found surrounded by one or
two membranes (onion-like particle). F) Rarely, aberrant virions with impaired nucleoid formation or G) mature virion (MV)-like particles with a non-
condensed core are observed alone and scattered in the cytoplasm. H–J) Representative images of DUSP1 KO cells infected with MVA showing
growing crescents (C) surrounding viroplasm foci (V). Also DNA accumulations (arrows), IVs and IVNs are observed. K–M) Representative images of
MVs frequently found in the cytoplasm of KO infected cells, L) sometimes engulfed into a large vesicle. N–O) Representative images of WV and EV.
Scale bars = 200 nm. P) Table representing the relative percentages of the different viral forms found in sections from 30 cells per cell line.
doi:10.1371/journal.ppat.1003719.g007
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By Western-blot and confocal microscopy on VACV-infected
DUSP1 WT and KO cells, we did not observe changes in
subcellular viral protein localization nor in proteolytic processing
of major core and viral structural proteins, like L4, A16 and A17.
This is consistent with previous studies that showed the same
phenotype when MVA infects non-permissive cell lines such as
HeLa [73]. However, when we analyzed the expression of the late
membrane protein A27, we found that A27 was incorporated in
virions in DUSP1 KO cells infected with MVA but its expression
was mostly diffuse across the cytoplasm in the case of DUSP1 WT
infected cells. These results point to an implication of DUSP1 in
the events that occur during the transition from IVN to MV. The
majority of the mutations that affect virion morphogenesis are
involved in this complex process [67]. Whether the role of DUSP1
in VACV morphogenesis is strictly dependent of viral protein
assembly or it is associated with other cellular processes remains to
be determined.
In fact, electron microscopy data of the viral morphogenesis
steps of DUSP1 WT and KO cells infected with MVA revealed
that MVA is able to complete its viral cycle in the absence of
DUSP1, further supporting the findings of time course analysis
and confocal microscopy. While all different viral forms
(crescents, IV, IVN, MV, WV and EV) were produced in
DUSP1 KO infected cells, similarly as it occurs during a
productive VACV infection, in WT MEFS the mature viral
forms MV and EV were greatly impaired, according to the
phenotype of a non-permissive cell line for MVA infection [56].
Comparative data of the different viral forms shows quantita-
tively that the main block in WT cells occurs at the transition
between IVN and MV.
We have also defined the influence of DUSP1 during VACV
replication in vivo in the mouse model. The increased weight
loss, higher death rate and worse disease prognosis after i.n.
inoculation with WR revealed that the absence of DUSP1 leads
to an increase susceptibility of infected mice. One possible cause
for this susceptibility could be an exacerbated pro-inflammatory
cytokine production but we did not find detectable levels of
these cytokines in lungs from DUSP1 WT or KO mice infected
with WR. However, we observed differences between cytokine
levels in serum from WT and KO mice infected with the
attenuated viruses MVA or NYVAC. Hence, the main possible
explanation for the susceptibility of DUSP1 KO mice to WR
infection may be the higher viral titers found in the lungs of
DUSP1 KO mice infected with WR in comparison with WT
mice.
Previous studies have shown the pivotal role of the modulation
of MAPK in host immune responses [74], [75]. Moreover, in
recent years, there has been an increasing amount of literature on
the role of DUSP1 in the inflammatory response against different
pathogens [40], [62], [76], [77]. Taking into account these data,
we considered interesting to address the involvement of DUSP1 in
innate and adaptive immune responses after VACV infection.
Measurement of cytokine production in the serum of infected mice
revealed that DUSP1 KO mice infected with NYVAC experi-
enced enhanced pro-inflammatory cytokine release as soon as
3 hpi, whereas in DUSP1 KO mice infected with MVA this
enhancement is observed at 24 hpi. These differences in the
kinetics of cytokine production may be explained by the fact that
these two VACV attenuated viruses lack different immunomod-
ulatory genes and, consequently, their immunogenicity profile
affects MAPK signaling pathway in a distinct manner.
In adaptive immune responses, MAPKs also serve as critical
regulators in the clonal expansion of effector T and B lymphocytes
through modulation of cytokine production, cell proliferation and
survival [78]. As a key MAPK modulator, DUSP1 may play an
important role during antiviral adaptive immune responses.
Therefore, we characterized the adaptive immune responses by
ICS after i.n. and i.p. inoculation with VACV. The results indicate
that even though there were differences in the magnitude of CD8+
T cell responses triggered by WR, MVA or NYVAC, viral-specific
CD8 T cell responses were higher in DUSP1 KO mice infected
than in WT animals, clearly suggesting that DUSP1 modulates
adaptive immune responses during VACV infection. As WR had
an enhanced replication in lungs from DUSP1 KO mice, the
amount of viral antigen produced was higher and longer expressed
in the organism with this fully competent replicating virus in
DUSP1 KO mice than in DUSP1 WT mice. In the case of the
attenuated MVA and NYVAC, the increased CD8+ T cell
response observed in DUSP1 KO mice might be related to the
different innate immune responses triggered by these viruses due
to the absence of different immunomodulatory genes in their
genomes [6], [79].
The adaptive immune responses triggered can be shaped by
the elicited innate immune response [80]. For instance,
dendritic cells (DCs) are one of the first lines of defense against
pathogens and the most important cells to bridge innate and
adaptive immunity [81]. In this sense, it has been recently
reported that DUSP1 has an essential role in the integration of
DC-signals and T cell responses, coordinating protective
immunity and immunopathology against bacteria and fungi
[82]. Thus, it is also possible that the absence of DUSP1 in
innate immune cells is responsible for the variations in T cell
responses observed after VACV infection.
In summary, this is the first report demonstrating the role of
DUSP1 during VACV infection. We can conclude that DUSP1
expression is specifically upregulated and phosphorylated during
VACV infection and that the activation of ERK by VACV is
necessary to promote DUSP1 phosphorylation. More interesting-
ly, host restriction of MVA replication in murine cells is overcome
when DUSP1 is absent and activation of MAPKs by virus
infection contributes to this enhanced replication. We have
demonstrated that DUSP1 is mainly acting at the transition
between IVN and MV. In addition, we have shown that DUSP1
deficiency results in an enhanced susceptibility of mice to WR
infection and this susceptibility could be related with an enhanced
viral replication in the lungs; meanwhile the more severe skin
lesions observed in DUSP1 KO mice were likely due to a host
inflammatory response triggered by MVA. Finally, we have
demonstrated that DUSP1 is involved in the modulation of innate
and adaptive immune responses during VACV infection. Overall,
DUSP1 acts as an antiviral host defense factor against a poxvirus
infection.
Figure 8. Activation of MAPKs contributes to the replication of MVA in DUSP1 KO MEFs. A) DUSP1 WT and KO cells were mock-infected
or infected with either WR, MVA or NYVAC at 5 PFU/cell. Samples were collected at 0.25, 0.5. 1, 2, 4, 6 and 8 hours post-infection and 50 mg of total
protein was analyzed by Western-blot using specific antibodies against P-ERK, ERK, P-JNK, JNK or tubulin. B) DUSP1 WT and KO cells were infected
with MVA at 0.01 PFU/cell and were mock-treated or treated with either ERK inhibitor UO126 (10 mM/30 min) or p38MAPK inhibitor SB203580 (5 mM/
1 h) at 0, 1 or 3 hpi. All samples were collected at 24 hpi and titrated in DF-1 cells by immunostaining plaque assay. Values shown are representative
from two independent experiments performed.
doi:10.1371/journal.ppat.1003719.g008
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Figure 9. DUSP1 KO mice are more susceptible to WR infection than WT mice. DUSP1 WT or KO mice (n = 5) were intranasally (i.n)
inoculated with either 56105 or 56106 PFU/mouse of WR. A) Mice were (individually) daily weighed and mean percentage weight loss of each group
was compared with the weight immediately prior to infection. B) Signs of illness (lack of activity, ruffled fur) were daily evaluated using arbitrary units
from 0 to 3 (healthy-ill). C) Survival rate after i.p. inoculation with WR. Different graphs show a representative example of two independent
experiments performed. p,0.05 (*), p,0.005 (**) and p,0.001 (***).
doi:10.1371/journal.ppat.1003719.g009
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Supporting Information
Figure S1 DUSP1 modulates WR replication in the
mouse model. Mice were intranasally (i.n) inoculated with
WR-luc (56106 PFU/mouse) and luciferase gene expression and
viral titers in the lungs from DUSP1 WT and KO-infected mice
were evaluated at days 2 and 5 post-infection (n = 4/day/group),
by luciferase activity and virus plaque assays as described under
Materials and Methods. Graph shows a representative example of
three independent experiments performed.
(PDF)
Figure S2 MVA and NYVAC replication during intra-
peritoneal infection in DUSP1 WT and KO mice. DUSP1
WT and KO mice (n = 4) were i.p inoculated with 26107 PFU/
mouse with MVA-luc (A) or NYVAC-luc (B). Mice tissue samples
were collected at 4 and 16 hpi. MVA replication in spleen, lymph
nodes testis and peritoneal washes, was measured as Luciferase
activity and represented as Units/mg tissue.
(PDF)
Figure S3 DUSP1 KO mice develop tail lesions after
MVA skin scarification. Mice (n = 4) were skin-scarified in the
tail with MVA (107 PFU/mouse) and were daily monitored for
lesion appearance. Representative images from DUSP1 WT and
KO mice at days 8 and 11 post-infection are shown. Three
independent experiments were performed.
(TIF)
Figure S4 Enhanced innate immune response during
VACV infection in the absence of DUSP1. Mice (n = 3) were
i.p inoculated with either WR (16107 PFU/mouse), MVA
(26107 PFU/mouse) or NYVAC (26107 PFU/mouse). IL-6,
TNF-a, IL-1b and IL-10 were analyzed by LUMINEX technol-
ogy from serum extracted at the indicated times post-infection.
(PDF)
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